Abstract
Background
Permanent pacing is often required following valve intervention (either surgical or percutaneous); however, tricuspid interventions pose specific challenges to conventional pacing. Therefore, leadless pacemaker (LP) implantation may be the preferred strategy when permanent pacing is required after tricuspid valve intervention.
Purpose
To report periprocedural outcomes and follow-up of patients undergoing implantation of a LP system following tricuspid valve interventions.
Methods
Patients with previous tricuspid valve intervention at the time of attempted implantation of a LP (MicraTM, Medtronic, Minneapolis, MN, USA) were included.
Results
Between 2019 and 2022, 40 patients underwent LP implantations following tricuspid interventions in 5 large tertiary centers. The mean age was 68.9 ± 13.7 years, and 48% patients were male. The indication for pacing was as following: AVB in 27 (68%) patients, AF with slow ventricular response in 10 (25%) patients, and refractory rapid atrial fibrillation (AF) referred to AV junction ablation in 3 (7%) patients. Most of the patients received Micra VR (78%). The procedure was successful in all patients. The mean procedural time is 58 ± 32 min, and the median fluoroscopy time is 7.5 min. Electrical parameters were within normal range (threshold: 1.35 ± 1.2 V@0.24 ms, impedance: 772 ± 245 Ohm, R-wave: 6.9 ± 5.4 mV). No acute complications were observed. During a mean follow-up of 10 months, electrical parameters remained stable, and 4 deaths were occurred (not related to the procedure).
Conclusion
A LP is a safe and efficient option following tricuspid valve interventions.
Graphical Abstract
Similar content being viewed by others
References
Mar PL, Angus CR, Kabra R, Migliore CK, Goswami R, John LA, et al. Perioperative predictors of permanent pacing and long-term dependence following tricuspid valve surgery: a multicentre analysis. Europace. 2017;19(12):1988–93.
Monteiro C, Ferrari ADL, Caramori PRA, Carvalho LAF, Siqueira DAA, Thiago L, et al. Permanent pacing after transcatheter aortic valve implantation: incidence, predictors and evolution of left ventricular function. Arq Bras Cardiol. 2017;109(6):550–9.
Udo EO, Zuithoff NP, van Hemel NM, de Cock CC, Hendriks T, Doevendans PA, et al. Incidence and predictors of short- and long-term complications in pacemaker therapy: the FOLLOWPACE study. Heart Rhythm. 2012;9(5):728–35.
Ostergaard L, Valeur N, Ihlemann N, Smerup MH, Bundgaard H, Gislason G, et al. Incidence and factors associated with infective endocarditis in patients undergoing left-sided heart valve replacement. Eur Heart J. 2018;39(28):2668–75.
Trankle CR, Gertz ZM, Koneru JN, Kasirajan V, Nicolato P, Bhardwaj HL, et al. Severe tricuspid regurgitation due to interactions with right ventricular permanent pacemaker or defibrillator leads. Pacing Clin Electrophysiol. 2018;41(7):845–53.
Martins RP, Galand V, Leclercq C, Daubert JC. Cardiac electronic implantable devices after tricuspid valve surgery. Heart Rhythm. 2018;15(7):1081–8.
Afzal MR, Daoud EG, Hussain S, Lloyd MS, Ellis C, Nangia V, et al. Multicenter experience of feasibility and safety of leadless pacemakers across bioprosthetic and repaired tricuspid valves. JACC Clin Electrophysiol. 2019;5(9):1093–4.
Theis C, Huber C, Kaesemann P, Kaiser B, Heinrich H, Albert M, et al. Implantation of leadless pacing systems in patients early after tricuspid valve surgery: a feasible option. Pacing Clin Electrophysiol. 2020;43(12):1486–90.
Garweg C, Vandenberk B, Foulon S, Poels P, Haemers P, Ector J, et al. Leadless pacemaker for patients following cardiac valve intervention. Arch Cardiovasc Dis. 2020;113(12):772–9.
Chang JD, Manning WJ, Ebrille E, Zimetbaum PJ. Tricuspid valve dysfunction following pacemaker or cardioverter-defibrillator implantation. J Am Coll Cardiol. 2017;69(18):2331–41.
Eleid MF, Blauwet LA, Cha YM, Connolly HM, Brady PA, Dearani JA, et al. Bioprosthetic tricuspid valve regurgitation associated with pacemaker or defibrillator lead implantation. J Am Coll Cardiol. 2012;59(9):813–8.
Morani G, Bolzan B, Pepe A, Ribichini FL. Leadless pacemaker through tricuspid bioprosthetic valve: Early experience. J Arrhythm. 2021;37(2):414–7.
Hwang J, Han S, Park HS, Lee CH, Kim IC, Jang WS. Implantation of a leadless pacemaker in a patient with mechanical tricuspid valve. HeartRhythm Case Rep. 2022;8(4):284–7.
Kerwin SA, Mayotte MJ, Gornick CC. Transcatheter pacemaker implantation in a patient with a bioprosthetic tricuspid valve. J Interv Card Electrophysiol. 2015;44(1):89–90.
Ollitrault P. Leadless pacemaker implantation in a patient with previous aortic, mitral, and tricuspid valve interventions. J Invasive Cardiol. 2021;33(10):E841.
Turdubaev A, Fink T, Eitz T, Imnadze G. Transfemoral leadless pacemaker implantation after transcatheter tricuspid valve in ring implantation. Clin Res Cardiol. 2024;113(1):187–9.
Terricabras M, Gul EE, Khaykin Y. Successful implantation of a leadless pacemaker in a patient with a tricuspid clip. CJC Open. 2021;3(10):1310–2.
Tang GH, Kaple R, Cohen M, Dutta T, Undemir C, Ahmad H, et al. First percutaneous Micra leadless pacemaker implantation and tricuspid valve repair with MitraClip NT for lead-associated severe tricuspid regurgitation. EuroIntervention. 2017;12(15):e1845–8.
Adukauskaite A, Hintringer F, Dichtl W, Muller S. Implantation of leadless pacemaker through neo-orifice after tricuspid valve edge-to-edge repair. Europace. 2020;22(6):869.
Reynolds D, Duray GZ, Omar R, Soejima K, Neuzil P, Zhang S, et al. A leadless intracardiac transcatheter pacing system. N Engl J Med. 2016;374(6):533–41.
Moore SKL, Chau KH, Chaudhary S, Rubin G, Bayne J, Avula UMR, et al. Leadless pacemaker implantation: a feasible and reasonable option in transcatheter heart valve replacement patients. Pacing Clin Electrophysiol. 2019;42(5):542–7.
Beurskens NEG, Tjong FVY, de Bruin-Bon RHA, Dasselaar KJ, Kuijt WJ, Wilde AAM, et al. Impact of leadless pacemaker therapy on cardiac and atrioventricular valve function through 12 months of follow-up. Circ Arrhythm Electrophysiol. 2019;12(5): e007124.
Hai JJ, Mao Y, Zhen Z, Fang J, Wong CK, Siu CW, et al. Close proximity of leadless pacemaker to tricuspid annulus predicts worse tricuspid regurgitation following septal implantation. Circ Arrhythm Electrophysiol. 2021;14(5): e009530.
Arkles JS, Epstein AE. Leadless pacemakers and the tricuspid valve: can you believe it? Can this be true? Circ Arrhythm Electrophysiol. 2019;12(5): e007375.
Gul EE, Haseeb YB, Haseeb S, Abuelatta R, Al AO. Successful leadless pacemaker implantation in a patient with profound bradycardia following transcatheter aortic valve replacement and mitral valve-in-valve procedure. Turk Kardiyol Dern Ars. 2020;48(4):443–6.
Author information
Authors and Affiliations
Contributions
All authors have made substantive contributions to the study, and all authors endorse the data and conclusions.
Corresponding author
Ethics declarations
Ethics approval
This retrospective study was approved by the Institutional Review Board of Istanbul Atlas University.
Conflict of interest
The authors declare no competing interests.
Additional information
All authors declare that the manuscript, as submitted or its essence in another version, is not under consideration for publication elsewhere, and it will not be submitted elsewhere until a final decision is made by the editors of the Journal of Interventional Cardiac Electrophysiology.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Gul, E.E., Baudinaud, P., Waldmann, V. et al. Leadless pacemaker implantation following tricuspid interventions: multicenter collaboration of feasibility and safety. J Interv Card Electrophysiol (2024). https://doi.org/10.1007/s10840-024-01796-w
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10840-024-01796-w